Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure

BACKGROUND: Diabetes mellitus (DM) patients surviving myocardial infarction (MI) exhibit a substantially higher incidence of subsequent heart failure (HF). Neuregulin (NRG)-1 and erythroblastic leukemia viral oncogene homolog (ErbB) receptors have been shown to play a critical role in maintenance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Odiete, Oghenerukevwe, Konik, Ewa A, Sawyer, Douglas B, Hill, Michael F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617023/
https://www.ncbi.nlm.nih.gov/pubmed/23530877
http://dx.doi.org/10.1186/1475-2840-12-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617023/
https://www.ncbi.nlm.nih.gov/pubmed/23530877
http://dx.doi.org/10.1186/1475-2840-12-52

Ejemplares similares